Apoptosis resistance in ulcerative colitis: High expression of decoy receptors by lamina propria T cells

European Journal of Immunology

Volumn 36, Issue 8, 2006, Pages 2215-2222

  Fayad, Raja ^a   Brand, Marc I ^b   Stone, David ^a   Keshavarzian, Ali ^b   Qiao, Liang ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY   (United States)

Author keywords

Apoptosis; Inflammation; Mucosa; T cells

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; DECOY RECEPTOR; FAS ANTIGEN; FC RECEPTOR; LIPOCORTIN 5; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY CD3; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LAMINA PROPRIA; LYMPHOCYTE ACTIVATION; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULCERATIVE COLITIS;

ADULT; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; COLITIS, ULCERATIVE; FAS LIGAND PROTEIN; FEMALE; HEALTH; HUMANS; INTESTINAL MUCOSA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 33747415823     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535477     Document Type: Article

References (33)

1. Loftus, E. V., Jr. and Sandborn, W. J., Epidemiology of inflammatory bowel disease. Gastroenterol. Clin. North Am. 2002. 31: 1-20.
2. Loftus, E. V., Jr., Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004. 126: 1504-1517.
3. Bouma, G. and Strober, W., The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003. 3: 521-533.
4. Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S. and Strober, W., Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002. 17: 629-638.
5. Bu, P., Keshavarzian, A., Stone, D. D., Liu, J., Le, P. T., Fisher, S. and Qiao, L., Apoptosis: One of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J. Immunol. 2001. 166: 6399-6403.
6. Levine, A. D. and Fiocchi, C., Regulation of life and death in lamina propria T cells. Semin. Immunol. 2001. 13: 195-199.
7. Neurath, M. F., Finotto, S., Fuss, I, Boirivant, M., Galle, P. R. and Strober, W., Regulation of T-cell apoptosis in inflammatory bowel disease: To die or not to die, that is the mucosal question. Trends Immunol. 2001. 22: 21-26.
8. Boirivant, M., Pica, R., DeMaria, R., Testi, R., Pallone, F. and Strober, W., Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J. Clin. Invest. 1996. 98: 2616-2622.
9. Koornstra, J. J., Kleibeuker, J. H., van Geelen, C. M., Rijcken, F. E., Hollema, H., de Vries, E. G. and de Jong, S., Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas. J. Pathol. 2003. 200: 327-335.
10. MacFarlane, M., Ahmad, M., Srinivasula, S. M., Fernandes-Alnemri, T., Cohen, G. M. and Alnemri, E. S., Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 1997. 272: 25417-25420.
11. Sarker, M., Ruiz-Ruiz, C. and Lopez-Rivas, A., Activation of protein kinase C inhibits TRAIL-induced caspases activation, mitochondrial events and apoptosis in a human leukemic T cell line. Cell Death Differ. 2001. 8: 172-181.
12. Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L. et al., Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997. 277: 818-821.
13. Shipman, C. M. and Croucher, P. I., Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/ APO2 ligand and can function as a paracrine survival factor for human myeloma cells. Cancer Res. 2003. 63: 912-916.
14. Ashkenazi, A. and Dixit, V. M., Death receptors: Signaling and modulation. Science 1998. 281: 1305-1308.
15. Pan, G., Ni, J., Wei, Y. F., Yu, G., Gentz, R. and Dixit, V. M., An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997. 277: 815-818.
16. Gura, T., How TRAIL kills cancer cells, but not normal cells. Science 1997. 277: 768.
17. Roth, W., Isenmann, S., Nakamura, M., Platten, M., Wick, W., Kleihues, P., Bahr, M. et al., Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res. 2001. 61: 2759-2765.
18. Wroblewski, V. J., Witcher, D. R., Becker, G. W., Davis, K. A., Dou, S., Micanovic, R., Newton, C. M. et al., Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem. Pharmacol. 2003. 65: 657-667.
19. Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A. et al., Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998. 396: 699-703.
20. De Maria, R., Boirivant, M., Cifone, M. G., Roncaioli, P., Hahne, M., Tschopp, J., Pallone, F. et al., Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J. Clin. Invest. 1996. 97: 316-322.
21. Boirivant, M., Marini, M., Di Felice, G., Pronio, A. M., Montesani, C., Tersigni, R. and Strober, W., Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999. 116: 557-565.
22. Ghoreschi, K., Muders, M. and Enders, G. A., Functional role of CD95 ligand in concanavalin A-induced intestinal intraepithelial lymphocyte cytotoxicity. Immunology 1998. 95: 566-571.
23. Melgar, S., Hammarstrom, S., Oberg, A., Danielsson, A. and Hammarstrom, M. L., Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine. Scand. J. Immunol. 2004. 60: 167-177.
24. Ueyama, H., Kiyohara, T., Sawada, N., Isozaki, K., Kitamura, S., Kondo, S., Miyagawa, J. et al., High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut 1998. 43: 48-55.
25. Yukawa, M., Iizuka, M., Horie, Y., Yoneyama, K., Shirasaka, T., Itou, H., Komatsu, M. et al., Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis. Int. J. Colorectal. Dis. 2002. 17: 70-76.
26. + T cells in the inflamed mucosa of ulcerative colitis. Scand. J. Gastroenterol. 2000. 35: 1278-1283.
27. Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V. K. and Weiner, H. L., Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995. 376: 177-180.
28. Marth, T., Strober, W. and Kelsall, B. L., High dose oral tolerance in ovalbumin TCR-transgenic mice: Systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J. Immunol. 1996. 157: 2348-2357.
29. Itoh, J., de La Motte, C., Strong, S. A., Levine, A. D. and Fiocchi, C., Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001. 49: 35-41.
30. Ina, K., Itoh, J., Fukushima, K., Kusugami, K., Yamaguchi, T., Kyokane, K., Imada, A. et al., Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol. 1999. 163: 1081-1090.
31. Fiocchi, C., Mucosal immunity. Gastroenterol. Intl. 1989. 2: 172-179.
32. Brandtzaeg, P., Halstensen, T. S., Kett, K., Krajci, P., Kvale, D., Rognum, T. O., Scott, H. and Sollid, L. M., Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989. 97: 1562-1584.
33. Liu, Z., Geboes, K., Colpaert, S., D'Haens, G. R., Rutgeerts, P. and Ceuppens, J. L., IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 2000. 164: 3608-3615.